Focalin and Luvox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Focalin (dexmethylphenidate hydrochloride) and Luvox (fluvoxamine maleate). Common drug interactions include autoimmune disorder among females and exostosis among males.

The phase IV clinical study analyzes what interactions people have when they take Focalin and Luvox. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Focalin?

Focalin has active ingredients of dexmethylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 4,781 Focalin users. Check the latest studies of Focalin.

What is Luvox?

Luvox has active ingredients of fluvoxamine maleate. It is often used in obsessive-compulsive disorder. eHealthMe is studying from 13,440 Luvox users. Check the latest studies of Luvox.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

11 people who take Focalin and Luvox together, and have interactions are studied.

Focalin and Luvox drug interactions.

What are the common drug interactions of Focalin and Luvox, by gender? *:

female:

  1. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  2. Oral herpes (viral infection of mouth)
  3. Sinusitis (inflammation of sinus)
  4. Abnormal sleep-related event

male:

  1. Exostosis (formation of new bone on the surface of a bone)
  2. Gait disturbance
  3. Drug ineffective
  4. Dry skin
  5. Overdose
  6. Pruritus generalised (generalized itching)
  7. Somnolence (a state of near-sleep, a strong desire for sleep)
  8. Abnormal behaviour
  9. Autism (a mental condition, present from early childhood, characterized by difficulty in communicating and forming relationships with other people and in using language and abstract concepts)
  10. Chronic kidney disease

What are the common drug interactions of Focalin and Luvox, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Otitis media (inflammation of the middle ear)
  2. Scoliosis (a medical condition in which a person's spine is curved from side to side)
  3. Dry skin
  4. Pruritus generalised (generalized itching)
  5. Abnormal behaviour
  6. Autism (a mental condition, present from early childhood, characterized by difficulty in communicating and forming relationships with other people and in using language and abstract concepts)
  7. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
  8. Tic (a sudden, repetitive, nonrhythmic motor movement or vocalization involving discrete muscle groups)
  9. Exostosis (formation of new bone on the surface of a bone)
  10. Gait disturbance

20-29:

  1. Overdose
  2. Somnolence (a state of near-sleep, a strong desire for sleep)
  3. Tic (a sudden, repetitive, nonrhythmic motor movement or vocalization involving discrete muscle groups)

30-39:

  1. Abnormal sleep-related event

40-49:

n/a

50-59:

n/a

60+:

  1. Chronic kidney disease
  2. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  3. Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

  1. Stress And Anxiety: 2 people, 18.18%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 18.18%
  3. Growth Retardation (delayed growth): 2 people, 18.18%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 18.18%
  5. Tic (a sudden, repetitive, nonrhythmic motor movement or vocalization involving discrete muscle groups): 1 person, 9.09%
  6. Sleep Disorder: 1 person, 9.09%
  7. Pain: 1 person, 9.09%
  8. Neuropathy Peripheral (surface nerve damage): 1 person, 9.09%
  9. Neuralgia (pain in one or more nerves): 1 person, 9.09%
  10. Gilles De La Tourette Syndrome (a condition that causes people to make repeated, quick movements or sounds that they cannot control): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Focalin and Luvox?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Focalin and Luvox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Focalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Luvox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Focalin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Luvox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on dexmethylphenidate hydrochloride and fluvoxamine maleate (the active ingredients of Focalin and Luvox, respectively), and Focalin and Luvox (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: